Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

about

Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.Saliva as a Future Field in Psoriasis Research.

P2860

Q48142190-DDCF9170-2BF3-4544-BAD2-98A88752A4D8 Q55057884-85D01355-19A4-4A04-9F2B-41FB7FE6F3F1

P2860

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

Item

http://www.wikidata.org/entity/Q42340109

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

@en

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

@nl

type

Item

label

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

@en

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

@nl

prefLabel

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

@en

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

@nl

P1476

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis

@en

P2093

Anna Campanati

http://www.w3.org/2001/XMLSchema#string

Annamaria Offidani

http://www.w3.org/2001/XMLSchema#string

Davide Sartini

http://www.w3.org/2001/XMLSchema#string

Elisa Molinelli

http://www.w3.org/2001/XMLSchema#string

Giulia Di Ruscio

http://www.w3.org/2001/XMLSchema#string

Giulia Ganzetti

http://www.w3.org/2001/XMLSchema#string

Ivan Bobyr

http://www.w3.org/2001/XMLSchema#string

Monica Emanuelli

http://www.w3.org/2001/XMLSchema#string

Valerio Brisigotti

http://www.w3.org/2001/XMLSchema#string

P2860

Saliva as a diagnostic fluid.

Psoriasis: epidemiology.

Psoriasis comorbidities.

Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.

Immunopathogenesis of psoriasis.

Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.

Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6.

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.

Saliva: physiology and diagnostic potential in health and disease.

P304

10-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0300060515598902

http://www.w3.org/2001/XMLSchema#string

P433

1 suppl

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Santarelli

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27683132

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5536539

http://www.w3.org/2001/XMLSchema#string

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

about

P2860

P2860

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932